Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 2/20 | 0.41 |
| ▸ | NSD2 | O96028 | 2/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | S100A4 | P26447 | 4/20 | 0.37 |
| ▸ | CDC25B | P30305 | 3/20 | 0.37 |
| ▸ | PTPRC | P08575 | 2/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.37 |
| ▸ | PADI1 | Q9ULC6 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30371886 | 0.90 | LRRK2 (0.42) | BLMTDP1PTPRCCTSLCTSS | |
| SCHEMBL249961 | 0.90 | LRRK2 (0.42) | BLMTDP1PTPRCCTSLCTSS | |
| SCHEMBL28084904 | 0.87 | TDP2 (0.34) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL17354059 | 0.85 | PTPRC (0.33) | TDP2NSD2PAX8ABL1PLCG1 | |
| Oxalic Acid SCHEMBL28571729 | 0.80 | PTGS1 (0.43) | TDP2NSD2PAX8ABL1PLCG1 | |
| Oxalic Acid SCHEMBL28577579 | 0.80 | PTGS1 (0.43) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL2147475 | 0.79 | GABRG2 (0.39) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL5255739 | 0.79 | MAPT (0.43) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL1924875 | 0.79 | CNR2 (0.35) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL4240536 | 0.79 | MAP4K4 (0.43) | TDP2NSD2PAX8ABL1PLCG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2096499-A1 | Toner compositions | Xerox Corporation (US) | 2009-09-02 | — | — | EP | claimed |
| US-20090214972-A1 | TONER COMPOSITIONS | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | claimed |
| US-20050214759-A1 | Enzymatic redox labelling of nucleic acids | WLASSOF WJATSCHESSLAW | 2005-09-29 | — | — | US | claimed |
| EP-1468006-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2004-10-20 | — | — | EP | claimed |
| WO-2003055898-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2003-07-10 | — | — | WO | claimed |
| WO-2023183813-A2 | BORON-CAPPED CLATHROCHELATE AND MACROCYCLIC LIGANDS AND METAL COMPLEXES THEREOF | U-REIF INVESTMENTS LIMITED PARTNERSHIP (CA) | 2023-09-28 | — | — | WO | disclosed |
| US-20200129645-A1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | GEORG-AUGUST-UNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS (DE) | 2020-04-30 | — | — | US | disclosed |
| EP-3641835-A1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts (DE) | 2020-04-29 | — | — | EP | disclosed |
| EP-2816038-B1 | HOPO CHELATORS | LUMIPHORE INC (US) | 2019-11-20 | — | — | EP | disclosed |
| US-10352938-B2 | Macrocyclic HOPO chelators | LUMIPHORE, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| WO-2018234236-A1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | GEORG-AUGUST-UNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS (DE) | 2018-12-27 | — | — | WO | disclosed |
| US-20160320399-A1 | MACROCYCLIC HOPO CHELATORS | LUMIPHORE, INC. | 2016-11-03 | — | — | US | disclosed |
| WO-2011025790-A1 | MACROCYCLIC HOPO CHELATORS | LUMIPHORE, INC. (US) | 2011-03-03 | — | — | WO | disclosed |
| US-20100173239-A1 | LOW MELT COLOR TONERS WITH FLUORESCENCE AGENTS | XEROX CORPORATION (US) | 2010-07-08 | — | — | US | disclosed |
| EP-2096499-A1 | Toner compositions | Xerox Corporation (US) | 2009-09-02 | — | — | EP | disclosed |
| US-20090214972-A1 | TONER COMPOSITIONS | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
| WO-2006106930-A1 | NUCLEIC ACID PROBE CONTAINING Eu3+ COMPLEX AND METHOD OF ANALYZING NUCLEIC ACID BY USING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-10-12 | — | — | WO | disclosed |
| US-20050214759-A1 | Enzymatic redox labelling of nucleic acids | WLASSOF WJATSCHESSLAW | 2005-09-29 | — | — | US | disclosed |
| EP-1468006-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003055898-A1 | ENZYMATIC REDOX LABELLING OF NUCLEIC ACIDS | UNISEARCH LIMITED (AU) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160320399-A1 | MACROCYCLIC HOPO CHELATORS | PHPT1, SSB, CD69 | TDP2 3912/4885NSD2 4222/4885PAX8 2638/4885 |
| US-10352938-B2 | Macrocyclic HOPO chelators | PHPT1, SSB, CD69 | TDP2 3912/4885NSD2 4222/4885PAX8 2638/4885 |
| US-20200129645-A1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | ATP1A2, ADORA1, ADORA3 | TDP2 4081/4885NSD2 2831/4885PAX8 3374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.